πŸ‡ΊπŸ‡Έ FDA
Patent

US 11236173

CD38 antibody

granted A61KA61K2039/507A61K39/39558

Quick answer

US patent 11236173 (CD38 antibody) held by BLACK BELT THERAPEUTICS LIMITED expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BLACK BELT THERAPEUTICS LIMITED
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/507, A61K39/39558, A61P, A61P35/00